Stock markets have responded positively to the Swiss food giant's earnings. But the maker of Nescafé, Maggi and Cailler is still a long way from its former heights.
UBS and Julius Baer reported their earnings for 2024 this week. Both banks are looking back on a successful year, however, their share prices fell sharply.
The outlook for the global semiconductor industry is promising, not least because of the expected increase in chip demand for AI applications. Swiss suppliers could also benefit.
Chinese start-up DeepSeek is challenging the dominance of US tech giants with its latest AI model. As a result, Nvidia's shares have suffered a historic setback.
The classic trainers with the three stripes are popular. Adidas' latest quarterly earnings seem to confirm this.
The major US banks are looking back on a successful 2024.
UBS shares are currently as expensive as they were in May 2008. However, the ongoing debate about the appropriate capitalisation of the banking giant remains a source of uncertainty.
Equity Top Picks 2025: Building Exposure with Reverse Convertibles.
The research at Zürcher Kantonalbank has identified ten equity top picks for the coming year. These include market heavyweights such as Holcim and Sonova, as well as smaller corporates such as the medtech company Ypsomed. Our structured products allow investors to make targeted investments in this selection.
| ZKB Barrier Reverse Convertible auf Humana Inc 151091456 / CH1510914562 |
| ZKB Reverse Convertible auf Oscar Health Inc 149282128 / CH1492821280 |
| ZKB Barrier Reverse Convertible auf Humana Inc 149283603 / CH1492836031 |
| ZKB Autocallable Reverse Convertible on worst of Eli Lilly & Co/Pfizer Inc/Unitedhealth Group In... 142531443 / CH1425314437 |
| ZKB Barrier Reverse Convertible on worst of Amazon.com Inc/Microsoft Corp/Meta Platforms Inc 149281224 / CH1492812248 |